Astrana Health COO withholds 1,790 shares for tax

Astrana Health’s COO and CFO had shares withheld to cover RSU-related taxes and continues to hold a substantial equity position.

Rhea-AI Filing Summary

Astrana Health, Inc. (ASTH) reported that its COO and CFO, Basho Chandan, had 1,790 shares of common stock withheld on September 5, 2026 to pay tax liabilities associated with vested restricted stock units, at a value of $38.47 per share. After this tax-withholding disposition, he holds 157,820 shares directly, including 15,202 shares of unvested restricted stock and additional restricted stock units scheduled to vest over time, all subject to continuous employment with Astrana Health.

Insider Trade Summary

Tax Withholding: 1,790 shares

Tax Withholding 1 txn

Insider Basho Chandan

Role COO and CFO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1, F2	1,790	$38.47	$69K

Holdings After Transaction: Common Stock — 157,820 shares (Direct)

Footnotes (2)

1. F1. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2026.
2. F2. Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 16,690 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027.

Key Figures

Shares disposed for tax withholding: 1,790 shares Per-share value for tax withholding: $38.47 per share Shares held after transaction: 157,820 shares +3 more

6 metrics

Shares disposed for tax withholding 1,790 shares Surrendered on September 5, 2026 to cover RSU tax liabilities

Per-share value for tax withholding $38.47 per share Value used for the 1,790-share tax-withholding disposition

Shares held after transaction 157,820 shares Direct common stock holdings by Basho Chandan after the September 5, 2026 transaction

Unvested restricted stock 15,202 shares Unvested restricted stock scheduled to vest on May 16, 2027, subject to continuous employment

Restricted stock units tranche 1 15,604 RSUs Vest in four equal semi-annual installments beginning October 2, 2026, subject to continuous employment

Restricted stock units tranche 2 16,690 RSUs Vest in five equal semi-annual installments beginning March 5, 2027, subject to continuous employment

Key Terms

restricted stock units, tax withholding obligations, unvested restricted stock, semi-annual installments, +1 more

5 terms

restricted stock units financial

"Also includes the following restricted stock units, which will vest as follows"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"surrender of shares to offset against tax withholding obligations associated"

unvested restricted stock financial

"Includes 15,202 shares of unvested restricted stock which will vest"

semi-annual installments financial

"will vest in four equal semi-annual installments beginning on October 2, 2026"

continuous employment with the Issuer financial

"in each case subject to continuous employment with the Issuer"

FAQ

What transaction did Astrana Health (ASTH) report for Basho Chandan on this Form 4?

Astrana Health reported that COO and CFO Basho Chandan had 1,790 shares of common stock withheld on September 5, 2026 to pay tax liabilities related to vested restricted stock units at a value of $38.47 per share.

Was the ASTH Form 4 transaction a market sale or purchase?

No. The Form 4 reports a tax-withholding disposition, where 1,790 shares were surrendered to cover tax withholding obligations on vested restricted stock units, rather than an open-market sale or purchase.

How many Astrana Health (ASTH) shares does Basho Chandan hold after the transaction?

After the September 5, 2026 tax-withholding transaction, COO and CFO Basho Chandan directly holds 157,820 shares of Astrana Health common stock, including unvested restricted stock and restricted stock units that will vest over time.

What unvested equity awards in ASTH does Basho Chandan have outstanding?

His holdings include 15,202 shares of unvested restricted stock vesting on May 16, 2027, plus 15,604 RSUs vesting in four equal semi-annual installments from October 2, 2026, and 16,690 RSUs vesting in five equal semi-annual installments from March 5, 2027, all subject to continuous employment.

Was the ASTH Form 4 transaction under a Rule 10b5-1 trading plan?

The filing indicates no Rule 10b5-1 trading plan for this transaction. The tax-withholding disposition of 1,790 shares to satisfy RSU-related tax obligations is reported without reference to any pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:41 PM Accepted by SEC EDGAR 09/08/2026 - 04:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Basho Chandan

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)

ALHAMBRA CALIFORNIA 91801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/05/2026		F		1,790(1)	D	$38.47	157,820(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2026.

2. Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 16,690 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027.

	/s/ Kathy Diep, as Attorney-in-Fact	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)